P C Hayes Selected Research

Secondary Prevention

7/2006

Review article: recent advances in the management of bleeding gastric varices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P C Hayes Research Topics

Disease

21	Fibrosis (Cirrhosis) 01/2018 - 02/2000
13	Hemorrhage 04/2012 - 03/2001
12	Liver Diseases (Liver Disease) 01/2018 - 02/2000
10	Acute Liver Failure (Fulminant Hepatic Failure) 01/2017 - 12/2000
7	Infections 01/2018 - 02/2000
6	Hepatitis C 01/2021 - 10/2000
6	Hepatic Encephalopathy 01/2017 - 03/2004
6	Portal Hypertension 05/2012 - 03/2000
4	Varicose Veins (Varicose Vein) 04/2012 - 08/2003
4	Chronic Hepatitis C 03/2012 - 02/2000
4	Ascites 11/2006 - 03/2000
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 02/2000
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 10/2000
3	Hepatitis 01/2017 - 12/2000
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2013 - 03/2009
3	End Stage Liver Disease 11/2013 - 12/2000
3	Liver Failure 08/2013 - 11/2001
3	Esophageal and Gastric Varices (Esophageal Varices) 11/2008 - 08/2002
2	Critical Illness (Critically Ill) 08/2013 - 02/2011
2	Intracranial Hypertension 02/2011 - 07/2001
2	Hypotension (Low Blood Pressure) 03/2009 - 03/2002
2	Virus Diseases (Viral Diseases) 04/2003 - 12/2000
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2000 - 10/2000
1	Hepatitis E 01/2017
1	Autoimmune Hepatitis 01/2015
1	Type 2 Diabetes Mellitus (MODY) 04/2012
1	Chronic Renal Insufficiency 09/2011
1	Hypertension (High Blood Pressure) 09/2011
1	Acute Kidney Injury (Acute Renal Failure) 09/2011
1	Endotoxemia 02/2011
1	Shock 02/2011
1	Non-alcoholic Fatty Liver Disease 04/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2010
1	Sinistral Portal Hypertension 07/2006
1	Chronic Hepatitis B 12/2004
1	Hyperammonemia 09/2004
1	Brain Diseases (Brain Disorder) 03/2004

Drug/Important Bio-Agent (IBA)

10	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017 - 01/2000
6	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2003
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2011 - 02/2000
3	Hyaluronic Acid (Hyaluronan)IBA 01/2018 - 10/2000
3	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 04/2003
3	EnzymesIBA 11/2013 - 02/2000
3	Thrombin FDA Link 04/2012 - 08/2003
3	Endothelin-1 (Endothelin 1)IBA 09/2006 - 04/2001
3	Endothelins (Endothelin)IBA 09/2006 - 04/2001
2	Coffee FDA Link 03/2016 - 11/2013
2	InterferonsIBA 06/2014 - 04/2003
2	Alanine Transaminase (SGPT)IBA 05/2012 - 04/2012
2	SodiumIBA 03/2012 - 04/2000
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2011 - 07/2003
2	cyclo(Trp-Asp-Pro-Val-Leu)IBA 09/2006 - 03/2003
2	Interferon-alpha (Interferon Alfa)IBA 12/2004 - 02/2000
1	Hepatitis B Core AntigensIBA 01/2018
1	AntibodiesIBA 01/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018
1	Proton Pump InhibitorsIBA 12/2016
1	SimeprevirIBA 06/2014
1	faldaprevirIBA 06/2014
1	SofosbuvirIBA 06/2014
1	NeopterinIBA 12/2013
1	Troponin IIBA 08/2013
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 05/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2012
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 03/2012
1	telaprevirIBA 03/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2012
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 03/2012
1	Eicosapentaenoic AcidIBA 04/2010
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2010
1	Docosahexaenoic AcidsIBA 04/2010
1	BQ 788IBA 09/2006
1	Tissue Adhesives (Tissue Adhesive)IBA 07/2006
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 04/2006
1	Arginine (L-Arginine)FDA Link 04/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2006
1	Vasoconstrictor AgentsIBA 04/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2006
1	adefovirIBA 12/2004
1	NucleosidesIBA 12/2004
1	Lamivudine (Epivir)FDA Link 12/2004
1	Immunologic Factors (Immunomodulators)IBA 12/2004
1	Amino Acids FDA Link 09/2004
1	AmmoniaIBA 09/2004
1	Glutamine (L-Glutamine)FDA Link 09/2004
1	SolutionsIBA 09/2004
1	BuffersIBA 09/2004
1	Hemoglobins (Hemoglobin)IBA 09/2004
1	Inositol (Myoinositol)IBA 09/2004

Therapy/Procedure

13	Stents 02/2011 - 03/2000
11	Therapeutics 01/2018 - 02/2000
11	Liver Transplantation 01/2017 - 02/2000
10	Transjugular Intrahepatic Portasystemic Shunt 02/2011 - 04/2000
4	Ligation 07/2006 - 04/2001
2	Critical Care (Surgical Intensive Care) 07/2011 - 02/2010
2	Artificial Liver (Bioartificial Liver) 02/2010 - 11/2001
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2011
1	Transplantation 09/2011
1	Secondary Prevention 07/2006
1	Splenectomy 07/2006